These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8581482)

  • 1. DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum.
    Ichikawa J; Meltzer HY
    Brain Res; 1995 Nov; 698(1-2):204-8. PubMed ID: 8581482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin 5-HT2C agonists selectively inhibit morphine-induced dopamine efflux in the nucleus accumbens.
    Willins DL; Meltzer HY
    Brain Res; 1998 Jan; 781(1-2):291-9. PubMed ID: 9507167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism.
    Bishop C; Tessmer JL; Ullrich T; Rice KC; Walker PD
    J Pharmacol Exp Ther; 2004 Aug; 310(2):687-94. PubMed ID: 15044557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic interaction between serotonin-2 receptor and dopamine D1 receptor stimulation on striatal preprotachykinin mRNA expression in the 6-hydroxydopamine lesioned rat.
    Gresch PJ; Walker PD
    Brain Res Mol Brain Res; 1999 Jun; 70(1):125-34. PubMed ID: 10381550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT 2A receptor stimulation by DOI, a 5-HT 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Kuroki T; Meltzer HY; Ichikawa J
    Brain Res; 2003 May; 972(1-2):216-21. PubMed ID: 12711095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of 5-HT2A/2C receptors within the nucleus accumbens increases local dopaminergic transmission.
    Yan QS
    Brain Res Bull; 2000 Jan; 51(1):75-81. PubMed ID: 10654584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the serotonin2A/2C receptor agonist and antagonist on phencyclidine-induced dopamine release in rat medial prefrontal cortex.
    Kuroki T; Kawahara T; Yonezawa Y; Tashiro N
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Oct; 23(7):1259-75. PubMed ID: 10581647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT2A and 5-HT2C/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum.
    Porras G; Di Matteo V; Fracasso C; Lucas G; De Deurwaerdère P; Caccia S; Esposito E; Spampinato U
    Neuropsychopharmacology; 2002 Mar; 26(3):311-24. PubMed ID: 11850146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin 2A receptor regulation of striatal neuropeptide gene expression is selective for tachykinin, but not enkephalin neurons following dopamine depletion.
    Basura GJ; Walker PD
    Brain Res Mol Brain Res; 2001 Aug; 92(1-2):66-77. PubMed ID: 11483243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
    Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum.
    Lucas G; Spampinato U
    J Neurochem; 2000 Feb; 74(2):693-701. PubMed ID: 10646521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evidence that 5-HT2C receptor antagonist but not agonist modulates cocaine-induced dopamine outflow in the rat nucleus accumbens and striatum.
    Navailles S; De Deurwaerdère P; Porras G; Spampinato U
    Neuropsychopharmacology; 2004 Feb; 29(2):319-26. PubMed ID: 14560323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of serotonin(1A) receptor agonism on antipsychotic drug-induced dopamine release in rat striatum and nucleus accumbens.
    Ichikawa J; Meltzer HY
    Brain Res; 2000 Mar; 858(2):252-63. PubMed ID: 10708676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of 3,4-methylenedioxymethamphetamine-induced dopamine release and serotonin neurotoxicity by 5-HT2 receptor agonists.
    Gudelsky GA; Yamamoto BK; Nash JF
    Eur J Pharmacol; 1994 Nov; 264(3):325-30. PubMed ID: 7698172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amperozide, a novel antipsychotic drug, inhibits the ability of d-amphetamine to increase dopamine release in vivo in rat striatum and nucleus accumbens.
    Ichikawa J; Meltzer HY
    J Neurochem; 1992 Jun; 58(6):2285-91. PubMed ID: 1349347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective stimulation of serotonin2c receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration.
    Di Matteo V; Pierucci M; Esposito E
    J Neurochem; 2004 Apr; 89(2):418-29. PubMed ID: 15056285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine and serotonin interactions in the modulation of the expression of the immediate-early transcription factor, nerve growth factor-inducible B, in the striatum.
    Gervais J; Soghomonian JJ; Richard D; Rouillard C
    Neuroscience; 1999; 91(3):1045-54. PubMed ID: 10391482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of ipsapirone and S(-)-pindolol on dopamine release in rat striatum and nucleus accumbens.
    Ichikawa J; Meltzer HY
    Brain Res; 1999 Sep; 842(2):445-51. PubMed ID: 10526141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin 5-HT(2) receptor stimulation of dopamine release in the posterior but not anterior nucleus accumbens of the rat.
    Bowers BJ; Henry MB; Thielen RJ; McBride WJ
    J Neurochem; 2000 Oct; 75(4):1625-33. PubMed ID: 10987844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin2C receptor stimulation inhibits cocaine-induced Fos expression and DARPP-32 phosphorylation in the rat striatum independently of dopamine outflow.
    Devroye C; Cathala A; Maitre M; Piazza PV; Abrous DN; Revest JM; Spampinato U
    Neuropharmacology; 2015 Feb; 89():375-81. PubMed ID: 25446572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.